Welcome to the IDEAL Collaboration

The IDEAL Framework is for improving research in surgery, devices and non-pharmacological interventions.

Read more

About the Collaboration

Find out about the people behind the IDEAL Collaboration

Read More

Why we need the IDEAL Framework

Peter McCulloch talks about how we can sometimes get carried away with the enthusiasm and commercial imperatives for new surgical technologies. Such "enthusiasm bias" needs to be tempered with a rigorous framework for the evaluation of the effects of these technologies.

Explore the framework

Advisory service for designing studies in surgery or therapeutic devices

This free service is for clinicians and scientists doing research as part of a grant-funded research project, or as an unfunded service improvement.

Read more

Latest news and discussion

18 May 2022

DECIDE-AI: New reporting guidelines developed to improve AI in healthcare settings

Read More All news
Robotic Surgery team, by Army Medicine, licensed under CC BY 2.0

Get Involved

The IDEAL Collaboration thrives through an international network of clinicians, researchers, policymakers and members of the public. We need your help to improve the quality of research. Sign up for our email newsletter or join the network.

Find out more

IDEAL Twitter Feed

New reporting guidelines developed by Oxford researchers will ensure that early studies on using Artificial Intelligence (AI) to treat patients will give researchers the information needed to develop AI systems safely and effectively.


Early stage clinical evaluation is important to assess an AI system’s actual clinical performance.

This guideline outlines key items that should be reported in early stage clinical studies of AI-based decision support systems in healthcare

NEW PAPER in @NatureMedicine (led by Baptiste Vasey) providing guidance on reporting of early-stage clinical evaluation of #ArtificialIntelligence based clinical decision support systems focussing on clinical utility, safety and human factors

--> https://tinyurl.com/2p96tb5r

Load More...